Weiss Multi Strategy Advisers LLC Fennec Pharmaceuticals Inc. Transaction History

Weiss Multi Strategy Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.99 - $8.55 $145,179 - $207,226	-24,237 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.19 - $10.17 $4,598 - $9,010	-886 Reduced 3.53%	24,237 $147,000
Q2 2020 Aug 14, 2020	SELL	$5.43 - $9.39 $1,715 - $2,967	-316 Reduced 1.24%	25,123 $210,000
Q1 2020 May 15, 2020	SELL	$4.89 - $8.1 $5,188 - $8,594	-1,061 Reduced 4.0%	25,439 $151,000
Q4 2019 Feb 14, 2020	BUY	$4.25 - $6.49 $6,375 - $9,735	1,500 Added 6.0%	26,500 $172,000
Q4 2018 Feb 14, 2019	BUY	$5.37 - $8.39 $134,250 - $209,750	25,000 New	25,000 $160,000

14.9M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $139M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.